Haider Falih Shamikh Al-Saedi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Haider Falih Shamikh Al-Saedi has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Meeqaat H. Altrufi
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Kufa, Najaf 54001, Iraq
2 shared publications - Mohammed Ibrahim Rasool
Department of Pharmacology and Toxicology, College of Pharmacy, University of Kerbala, Karbala 56001, Iraq
2 shared publications Mukhallad Abdul Kareem Ramadhan
Department of Pathology, College of Medicine, University of Misan, Misan, Iraq
2 shared publications- Samer Ali Hasan
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Kufa, Najaf 54001, Iraq
2 shared publications - Waleed Khaled Albahadly
DEPARTMENT OF PHARMACOLOGY AND TOXICOLOGY, COLLEGE OF PHARMACY, UNIVERSITY OF KARBALA, KARBALA, IRAQ
2 shared publications Adeeb Ahmed Kadhim Al-Zubaidy
Department of Pharmacology and Toxicology, Pharmacy College-Al-Nahrain University, Iraq
1 shared publication
Latest Publications
- 7 October 2026
- Published by Bentham Science Publishers Ltd. in Recent Innovations in Chemical Engineering
- Vol. 19, 1-26
Enhancing Growth, Biochemical Composition, and Pigment Production in Spirulina platensis using Sugar Mill Effluent-supplemented Zarrouk’s Medium
Introduction: Spirulina platensis, a cyanobacterium used in food and health products, faces high cultivation costs due to synthetic media requirements. This study explores the use of sugar mill effluent (SME) as a supplement to Zarrouk's medium, aiming to lower production costs and aid in pollutant removal from wastewater. Materials and Methods: Physicochemical and nutritional aspects of SME were investigated. Spirulina platensis (NCIM 5143) was cultivated in Zarrouk’s medium supplemented with 50-100 mL/L of SME for 20 days. Studies were performed on biomass, biochemical composition, pigments, oxidative stress, heavy metals, and phycoremediation efficiency. Results: SME was nutrient-rich, containing 245 mg/L N, 28.5 mg/L P, and 310 mg/L K+. Growth increased significantly with SME concentration (p < 0.05), with SP4 producing maximum biomass, protein, pigments, and phycocyanin. Heavy metals remained within permissible limits, while COD and BOD removal reached 58.3% and 62.1%, respectively. Discussion: SME enhancement increased the biomass and biochemical composition of Spirulina by providing it with organic carbon and essential nutrients, which provided a cheaper option compared to the conventional Zarrouk’s medium. Elevated malondialdehyde and antioxidant pigments indicated increased oxidative stress. Moreover, Spirulina production allowed for sustainable pollutant disposal through SME reuse. Conclusion: Sugar mill effluent supplementation (100 mL/L) significantly improved the growth and biomass productivity of Spirulina platensis, while also enhancing pigment synthesis and achieving effective phycoremediation, resulting in 62% BOD and 58% COD removal. This method enables sustainable, cost-effective cultivation, reduces pollution, and produces safe biomass.
- 7 October 2026
- Published by Bentham Science Publishers Ltd. in Recent Innovations in Chemical Engineering
- Vol. 19, 1-26
Enhancing Growth, Biochemical Composition, and Pigment Production in Spirulina platensis using Sugar Mill Effluent-supplemented Zarrouk’s Medium
Introduction: Spirulina platensis, a cyanobacterium used in food and health products, faces high cultivation costs due to synthetic media requirements. This study explores the use of sugar mill effluent (SME) as a supplement to Zarrouk's medium, aiming to lower production costs and aid in pollutant removal from wastewater. Materials and Methods: Physicochemical and nutritional aspects of SME were investigated. Spirulina platensis (NCIM 5143) was cultivated in Zarrouk’s medium supplemented with 50-100 mL/L of SME for 20 days. Studies were performed on biomass, biochemical composition, pigments, oxidative stress, heavy metals, and phycoremediation efficiency. Results: SME was nutrient-rich, containing 245 mg/L N, 28.5 mg/L P, and 310 mg/L K+. Growth increased significantly with SME concentration (p < 0.05), with SP4 producing maximum biomass, protein, pigments, and phycocyanin. Heavy metals remained within permissible limits, while COD and BOD removal reached 58.3% and 62.1%, respectively. Discussion: SME enhancement increased the biomass and biochemical composition of Spirulina by providing it with organic carbon and essential nutrients, which provided a cheaper option compared to the conventional Zarrouk’s medium. Elevated malondialdehyde and antioxidant pigments indicated increased oxidative stress. Moreover, Spirulina production allowed for sustainable pollutant disposal through SME reuse. Conclusion: Sugar mill effluent supplementation (100 mL/L) significantly improved the growth and biomass productivity of Spirulina platensis, while also enhancing pigment synthesis and achieving effective phycoremediation, resulting in 62% BOD and 58% COD removal. This method enables sustainable, cost-effective cultivation, reduces pollution, and produces safe biomass.
- Open Access
Nicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling
Background: Cisplatin is a widely used chemotherapeutic agent whose clinical application is often limited by severe hepatorenal toxicity associated with oxidative stress and cellular injury. Nicotinamide riboside (NR), a natural precursor of nicotinamide adenine dinucleotide (NAD+), has emerged as a promising cytoprotective compound with antioxidant and metabolic regulatory properties. This study investigated the protective effects of NR against cisplatin-induced hepatorenal toxicity and explored its potential mechanisms of action. Methods: Thirty-six adult male Wistar rats were randomly assigned to four groups (n = 6): control, cisplatin (7 mg/kg, i.p.), nicotinamide riboside (50 mg/kg/day, orally), and cisplatin plus NR. Renal and hepatic function biomarkers, lipid profile parameters, oxidative stress markers, and antioxidant status were evaluated. Relative mRNA expression of Nrf2 and NQO1 was determined using RT-qPCR. Histopathological examinations of liver and kidney tissues were also performed. Results: Cisplatin administration induced marked hepatorenal injury, evidenced by significant elevations in serum KIM-1 (395.27 vs. 116.04 ng/mL), urea (71.16 vs. 21.33 mg/dL), creatinine (3.49 vs. 0.26 mg/dL), AST (325.83 vs. 95.16 U/L), and ALT (102.83 vs. 45.50 U/L), accompanied by dyslipidemia, oxidative stress, and severe histopathological alterations. NR treatment significantly attenuated these changes, reducing KIM-1, urea, creatinine, AST, and ALT by 55.5%, 47.8%, 48.1%, 55.4%, and 33.5%, respectively, compared with the cisplatin group. NR also improved antioxidant status by increasing GSH and SOD levels while reducing MDA and NO concentrations. Hepatic NAD+ levels and the NAD+/NADH ratio were significantly decreased by cisplatin and significantly restored by NR treatment. In addition, NR significantly upregulated the relative mRNA expression of Nrf2 and NQO1 and markedly preserved hepatic and renal histological architecture. Pharmacological inhibition of Nrf2 with ML385 significantly attenuated these protective effects of NR across biochemical, lipid, and oxidative stress parameters, confirming that they are, at least in part, Nrf2-dependent. Conclusions: Nicotinamide riboside exerts protective effects against cisplatin-induced hepatorenal toxicity that are mechanistically linked to activation of the Nrf2/NQO1 antioxidant pathway and restoration of hepatic NAD+ homeostasis. This finding supports the potential of NR as an adjunctive strategy for mitigating cisplatin-associated hepatorenal injury and warrants further preclinical and clinical investigation.
Open AccessNicotinamide Riboside Attenuates Cisplatin-Induced Hepatorenal Toxicity Through Restoration of NAD+ Homeostasis and Nrf2/NQO1-Dependent Antioxidant Signaling
Background: Cisplatin is a widely used chemotherapeutic agent whose clinical application is often limited by severe hepatorenal toxicity associated with oxidative stress and cellular injury. Nicotinamide riboside (NR), a natural precursor of nicotinamide adenine dinucleotide (NAD+), has emerged as a promising cytoprotective compound with antioxidant and metabolic regulatory properties. This study investigated the protective effects of NR against cisplatin-induced hepatorenal toxicity and explored its potential mechanisms of action. Methods: Thirty-six adult male Wistar rats were randomly assigned to four groups (n = 6): control, cisplatin (7 mg/kg, i.p.), nicotinamide riboside (50 mg/kg/day, orally), and cisplatin plus NR. Renal and hepatic function biomarkers, lipid profile parameters, oxidative stress markers, and antioxidant status were evaluated. Relative mRNA expression of Nrf2 and NQO1 was determined using RT-qPCR. Histopathological examinations of liver and kidney tissues were also performed. Results: Cisplatin administration induced marked hepatorenal injury, evidenced by significant elevations in serum KIM-1 (395.27 vs. 116.04 ng/mL), urea (71.16 vs. 21.33 mg/dL), creatinine (3.49 vs. 0.26 mg/dL), AST (325.83 vs. 95.16 U/L), and ALT (102.83 vs. 45.50 U/L), accompanied by dyslipidemia, oxidative stress, and severe histopathological alterations. NR treatment significantly attenuated these changes, reducing KIM-1, urea, creatinine, AST, and ALT by 55.5%, 47.8%, 48.1%, 55.4%, and 33.5%, respectively, compared with the cisplatin group. NR also improved antioxidant status by increasing GSH and SOD levels while reducing MDA and NO concentrations. Hepatic NAD+ levels and the NAD+/NADH ratio were significantly decreased by cisplatin and significantly restored by NR treatment. In addition, NR significantly upregulated the relative mRNA expression of Nrf2 and NQO1 and markedly preserved hepatic and renal histological architecture. Pharmacological inhibition of Nrf2 with ML385 significantly attenuated these protective effects of NR across biochemical, lipid, and oxidative stress parameters, confirming that they are, at least in part, Nrf2-dependent. Conclusions: Nicotinamide riboside exerts protective effects against cisplatin-induced hepatorenal toxicity that are mechanistically linked to activation of the Nrf2/NQO1 antioxidant pathway and restoration of hepatic NAD+ homeostasis. This finding supports the potential of NR as an adjunctive strategy for mitigating cisplatin-associated hepatorenal injury and warrants further preclinical and clinical investigation.
- Open Access
Topical Astaxanthin Attenuates Imiquimod-Induced Psoriasiform Dermatitis by Downregulating Psoriasis-Associated Keratin Gene Expression (Krt16, Krt17, Krt6a) and Inhibiting the JAK-STAT Signaling Pathway
Psoriasis is a chronic immune-mediated inflammatory skin disorder characterized by excessive keratinocyte proliferation, oxidative stress, and dysregulated cytokine signaling. Although topical corticosteroids remain the first-line therapy, their long-term use is often limited by adverse effects, highlighting the need for safer non-steroidal therapeutic alternatives. This study investigated the therapeutic efficacy and underlying mechanisms of a topical astaxanthin (AST) formulation in an imiquimod (IMQ)-induced mouse model of psoriasiform dermatitis. Following IMQ induction, mice were randomly assigned to vehicle, clobetasol, or AST treatment groups (0.5–1.5%) for 14 days. Disease progression was evaluated through biochemical analysis of oxidative stress biomarkers, including NADPH oxidase (NOX), malondialdehyde (MDA), nitric oxide (NO), and superoxide dismutase (SOD), as well as ELISA-based quantification of inflammatory cytokines (TNF-α, IL-6, IL-17, and IL-23). Histopathological changes were assessed using hematoxylin and eosin staining, while molecular alterations were examined by RT-qPCR analysis of psoriasis-associated keratin genes (Krt16, Krt17, and Krt6a) and evaluation of JAK–STAT signaling activity. AST treatment significantly suppressed the IL-23/IL-17 inflammatory axis, reduced NOX activity and lipid peroxidation, restored endogenous antioxidant defenses, and inhibited JAK–STAT signaling. These biochemical and molecular effects were accompanied by marked downregulation of keratin gene expression and substantial histological improvement, including normalization of epidermal thickness, reduced parakeratosis, and decreased inflammatory infiltration. Notably, high-dose AST demonstrated therapeutic efficacy comparable to, and in some parameters exceeding, that of clobetasol. Collectively, these findings indicate that topical astaxanthin exerts coordinated antioxidant, anti-inflammatory, and anti-proliferative effects, supporting its potential as a promising multi-target non-steroidal therapeutic candidate for psoriasis management.
Open AccessTopical Astaxanthin Attenuates Imiquimod-Induced Psoriasiform Dermatitis by Downregulating Psoriasis-Associated Keratin Gene Expression (Krt16, Krt17, Krt6a) and Inhibiting the JAK-STAT Signaling Pathway
Psoriasis is a chronic immune-mediated inflammatory skin disorder characterized by excessive keratinocyte proliferation, oxidative stress, and dysregulated cytokine signaling. Although topical corticosteroids remain the first-line therapy, their long-term use is often limited by adverse effects, highlighting the need for safer non-steroidal therapeutic alternatives. This study investigated the therapeutic efficacy and underlying mechanisms of a topical astaxanthin (AST) formulation in an imiquimod (IMQ)-induced mouse model of psoriasiform dermatitis. Following IMQ induction, mice were randomly assigned to vehicle, clobetasol, or AST treatment groups (0.5–1.5%) for 14 days. Disease progression was evaluated through biochemical analysis of oxidative stress biomarkers, including NADPH oxidase (NOX), malondialdehyde (MDA), nitric oxide (NO), and superoxide dismutase (SOD), as well as ELISA-based quantification of inflammatory cytokines (TNF-α, IL-6, IL-17, and IL-23). Histopathological changes were assessed using hematoxylin and eosin staining, while molecular alterations were examined by RT-qPCR analysis of psoriasis-associated keratin genes (Krt16, Krt17, and Krt6a) and evaluation of JAK–STAT signaling activity. AST treatment significantly suppressed the IL-23/IL-17 inflammatory axis, reduced NOX activity and lipid peroxidation, restored endogenous antioxidant defenses, and inhibited JAK–STAT signaling. These biochemical and molecular effects were accompanied by marked downregulation of keratin gene expression and substantial histological improvement, including normalization of epidermal thickness, reduced parakeratosis, and decreased inflammatory infiltration. Notably, high-dose AST demonstrated therapeutic efficacy comparable to, and in some parameters exceeding, that of clobetasol. Collectively, these findings indicate that topical astaxanthin exerts coordinated antioxidant, anti-inflammatory, and anti-proliferative effects, supporting its potential as a promising multi-target non-steroidal therapeutic candidate for psoriasis management.
- Open Access
- 5 December 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (12)
Development and Characterization of High-Performance 1.6 V Asymmetric Supercapacitor Using Mn₂O₃//rGO-TiO₂ in Aqueous Electrolyte
A supercapacitor cell in organic electrolyte with carbon-based electrodes has been commercialized. However, there are a few supercapacitor cell systems on the market that use aqueous electrolytes. In the current study, a high-performance supercapacitor cell is constructed in an asymmetric configuration using hydrothermally manufactured Mn2O3 microspheres as a positive electrode and hydrothermally synthesized rGO-TiO2 as a negative electrode in an aqueous electrolyte. The device provides a wide operational voltage window of 0 to 1.6 V, significantly surpassing the voltage ranges typically seen in aqueous-based supercapacitors. It achieves exceptional electrochemical performance metrics, including a high specific capacitance of 321 F g⁻¹, an energy density of 114 W h kg⁻¹ and a power density of 571 W kg⁻¹. These results show a significant improvement over symmetric designs like Mn₂O₃//Mn₂O₃ (energy density: 37 W h kg⁻¹ at 357 W kg⁻¹) and rGO-TiO₂//rGO-TiO₂ (energy density: 18 W h kg⁻¹ at 214 W kg⁻¹). The asymmetric cell has an energy density of 71 W h kg⁻¹ and an ultra-high power density of 57,142 W kg⁻¹, making it suitable for rapid energy delivery applications. Additionally, excellent stability during cycling is observed at a higher discharge current density of 10.71 A g-1, sustaining more than 82% of the initial capacitance after 10,000 charge-discharge cycles. The adoption of a CR2032 coin cell type emphasizes the practicality of this high-voltage aqueous supercapacitor device for next-generation energy management and storage applications
- 5 December 2025
- Published by IOP Publishing in Materials Research Express
- Vol. 12 (12)
Open AccessDevelopment and Characterization of High-Performance 1.6 V Asymmetric Supercapacitor Using Mn₂O₃//rGO-TiO₂ in Aqueous Electrolyte
A supercapacitor cell in organic electrolyte with carbon-based electrodes has been commercialized. However, there are a few supercapacitor cell systems on the market that use aqueous electrolytes. In the current study, a high-performance supercapacitor cell is constructed in an asymmetric configuration using hydrothermally manufactured Mn2O3 microspheres as a positive electrode and hydrothermally synthesized rGO-TiO2 as a negative electrode in an aqueous electrolyte. The device provides a wide operational voltage window of 0 to 1.6 V, significantly surpassing the voltage ranges typically seen in aqueous-based supercapacitors. It achieves exceptional electrochemical performance metrics, including a high specific capacitance of 321 F g⁻¹, an energy density of 114 W h kg⁻¹ and a power density of 571 W kg⁻¹. These results show a significant improvement over symmetric designs like Mn₂O₃//Mn₂O₃ (energy density: 37 W h kg⁻¹ at 357 W kg⁻¹) and rGO-TiO₂//rGO-TiO₂ (energy density: 18 W h kg⁻¹ at 214 W kg⁻¹). The asymmetric cell has an energy density of 71 W h kg⁻¹ and an ultra-high power density of 57,142 W kg⁻¹, making it suitable for rapid energy delivery applications. Additionally, excellent stability during cycling is observed at a higher discharge current density of 10.71 A g-1, sustaining more than 82% of the initial capacitance after 10,000 charge-discharge cycles. The adoption of a CR2032 coin cell type emphasizes the practicality of this high-voltage aqueous supercapacitor device for next-generation energy management and storage applications
- Open Access
- 12 November 2024
- Published by PHARMAKON-PRESS in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
- Vol. 38 (3) , 327-334
Vancomycin-induced acute kidney injury in rats: beneficial effects deriving from the co-administration of tadalafil or vitamin C
Background: Vancomycin (VAN) is widely employed in clinical settings for the treatment of severe infections attributable to multi-resistant bacteria, with a notable emphasis on Gram-positive strains. However, its therapeutic usage is significantly hampered by the potential for acute kidney injury (AKI); specifically, the nephrotoxic effects it can exert. In controlled experimental studies, the intraperitoneal (i.p.) administration of VAN at a dose of 400 mg/kg/day over a consecutive seven-day period has been shown to induce considerable AKI in rats. In addressing this concern, vitamin C (VC), recognized traditionally for its antioxidant properties, has been utilized to mitigate various forms of organ damage and inflammatory responses, primarily by diminishing oxidative stress and attenuating inflammation. Concurrently, tadalafil (TAD), a phosphodiesterase type-5 inhibitor commonly associated with the treatment of erectile dysfunction, is also noted for its beneficial anti-inflammatory and antioxidant effects, alongside vasodilatory properties. Aim: This study was designed in order to investigate the protective capabilities of TAD or VC against the VAN-induced nephrotoxic effects in a rat model of AKI. Methodology: A total of 24 male albino Wistar rats were allocated into four distinct groups for the purpose of comparative analysis. Following treatment, both kidney and blood samples were obtained for further evaluation. The study randomized the rats into four categories: group 1 served as the control group, group 2 received VAN at a dosage of 400 mg/kg (via an i.p. injection on a daily basis), group 3 was administered VAN (400 mg/kg; i.p., daily) in conjunction with TAD at a dose of 5 mg/kg daily, and group 4 was given VAN (400 mg/kg; i.p., daily) alongside VC at a dosage of 200 mg/kg daily. Results: Evaluations included the measurement of renal function indicators such as the serum levels of urea, of creatinine, and the creatinine clearance. Additionally, the analysis involved the assessment of antioxidant markers in renal tissue homogenates, including malondialdehyde (MDA), glutathione, and superoxide dismutase. To further elucidate the inflammatory response, indices such as the levels of the tumor necrosis factor-alpha, the interleukins (IL)-1β and IL-6, and the nuclear factor-κB were evaluated within the renal tissue homogenate samples of the studied rats. The administration of VAN resulted in a marked elevation of renal biomarkers and inflammatory indices, alongside a significant reduction in antioxidant levels, with an exception for MDA (which exhibited increased levels); these changes reached statistical significance (p<0.05) when measured against the control group. In contrast, the supplementation with TAD or VC was effective in significantly lowering the serum levels of both renal and inflammatory indicators when compared to the group treated solely with VAN. Furthermore, antioxidant measurements improved, alongside a reduction in MDA levels, thereby demonstrating significant differences (p<0.05). Conclusion: The findings of this study reveal that both TAD and VC provide a degree of renal protection against the VAN-induced damage by enhancing kidney function markers and, concurrently, lessening oxidative stress and inflammatory responses associated with nephrotoxicity.
- 12 November 2024
- Published by PHARMAKON-PRESS in Review of Clinical Pharmacology and Pharmacokinetics - International Edition
- Vol. 38 (3) , 327-334
Open AccessVancomycin-induced acute kidney injury in rats: beneficial effects deriving from the co-administration of tadalafil or vitamin C
Background: Vancomycin (VAN) is widely employed in clinical settings for the treatment of severe infections attributable to multi-resistant bacteria, with a notable emphasis on Gram-positive strains. However, its therapeutic usage is significantly hampered by the potential for acute kidney injury (AKI); specifically, the nephrotoxic effects it can exert. In controlled experimental studies, the intraperitoneal (i.p.) administration of VAN at a dose of 400 mg/kg/day over a consecutive seven-day period has been shown to induce considerable AKI in rats. In addressing this concern, vitamin C (VC), recognized traditionally for its antioxidant properties, has been utilized to mitigate various forms of organ damage and inflammatory responses, primarily by diminishing oxidative stress and attenuating inflammation. Concurrently, tadalafil (TAD), a phosphodiesterase type-5 inhibitor commonly associated with the treatment of erectile dysfunction, is also noted for its beneficial anti-inflammatory and antioxidant effects, alongside vasodilatory properties. Aim: This study was designed in order to investigate the protective capabilities of TAD or VC against the VAN-induced nephrotoxic effects in a rat model of AKI. Methodology: A total of 24 male albino Wistar rats were allocated into four distinct groups for the purpose of comparative analysis. Following treatment, both kidney and blood samples were obtained for further evaluation. The study randomized the rats into four categories: group 1 served as the control group, group 2 received VAN at a dosage of 400 mg/kg (via an i.p. injection on a daily basis), group 3 was administered VAN (400 mg/kg; i.p., daily) in conjunction with TAD at a dose of 5 mg/kg daily, and group 4 was given VAN (400 mg/kg; i.p., daily) alongside VC at a dosage of 200 mg/kg daily. Results: Evaluations included the measurement of renal function indicators such as the serum levels of urea, of creatinine, and the creatinine clearance. Additionally, the analysis involved the assessment of antioxidant markers in renal tissue homogenates, including malondialdehyde (MDA), glutathione, and superoxide dismutase. To further elucidate the inflammatory response, indices such as the levels of the tumor necrosis factor-alpha, the interleukins (IL)-1β and IL-6, and the nuclear factor-κB were evaluated within the renal tissue homogenate samples of the studied rats. The administration of VAN resulted in a marked elevation of renal biomarkers and inflammatory indices, alongside a significant reduction in antioxidant levels, with an exception for MDA (which exhibited increased levels); these changes reached statistical significance (p<0.05) when measured against the control group. In contrast, the supplementation with TAD or VC was effective in significantly lowering the serum levels of both renal and inflammatory indicators when compared to the group treated solely with VAN. Furthermore, antioxidant measurements improved, alongside a reduction in MDA levels, thereby demonstrating significant differences (p<0.05). Conclusion: The findings of this study reveal that both TAD and VC provide a degree of renal protection against the VAN-induced damage by enhancing kidney function markers and, concurrently, lessening oxidative stress and inflammatory responses associated with nephrotoxicity.
- Open Access
- 15 May 2023
- Published by Springer Nature in Emergent Materials
- Vol. 6 (4) , 1167-1176
Nitrogen and sulfur co-doped activated carbon nanosheets for high-performance coin cell supercapacitor device with outstanding cycle stability
Herein, we report the utilization of nitrogen and sulfur dual heteroatoms co-doped activated carbon (NSAC) by hydrothermal method for electrochemical supercapacitors. Various NSACs were made by using a fixed amount of activated carbon and changing the amounts of thioacetamide. From NSAC electrodes, the coin cell configuration was fabricated and the overall electrochemical conduct was evaluated by using cyclic voltammetry, galvanostatic charge-discharge, cycle life, and electrochemical impedance methodologies. The outcomes manifest that co-doping sulfur and nitrogen into the AC improves the electrochemical performance. In comparison to pure activated carbon, the optimized NSAC produced a higher specific capacitance value of 417 F g−1 at 0.7 A g−1 and also demonstrated outstanding charge-discharge cycling stability at 7 mA (5 A g−1), maintaining 76% of its opening capacitance after 60,000 cycles in the CR2032 device configuration. The impedance studies phase angle value of 85° has added evidence of the NSAC’s good capacitor performance. Thus, we believe this work is suitable for practical applications for energy storage devices. Graphical abstract
- 15 May 2023
- Published by Springer Nature in Emergent Materials
- Vol. 6 (4) , 1167-1176
Open AccessNitrogen and sulfur co-doped activated carbon nanosheets for high-performance coin cell supercapacitor device with outstanding cycle stability
Herein, we report the utilization of nitrogen and sulfur dual heteroatoms co-doped activated carbon (NSAC) by hydrothermal method for electrochemical supercapacitors. Various NSACs were made by using a fixed amount of activated carbon and changing the amounts of thioacetamide. From NSAC electrodes, the coin cell configuration was fabricated and the overall electrochemical conduct was evaluated by using cyclic voltammetry, galvanostatic charge-discharge, cycle life, and electrochemical impedance methodologies. The outcomes manifest that co-doping sulfur and nitrogen into the AC improves the electrochemical performance. In comparison to pure activated carbon, the optimized NSAC produced a higher specific capacitance value of 417 F g−1 at 0.7 A g−1 and also demonstrated outstanding charge-discharge cycling stability at 7 mA (5 A g−1), maintaining 76% of its opening capacitance after 60,000 cycles in the CR2032 device configuration. The impedance studies phase angle value of 85° has added evidence of the NSAC’s good capacitor performance. Thus, we believe this work is suitable for practical applications for energy storage devices. Graphical abstract
- 31 October 2022
- Vol. 77 (5) , 1945-1952
Pharmaceutical Characterization and in vivo Evaluation of the Possible Anti-Inflammatory Effect of Topical Allopurinol Gel in an Animal Model
Dermatitis, like inflammation, is a group of common dermatological symptoms and may be associated with systemic and skin diseases. The objective of the current study is to evaluate the potential anti-inflammatory effect of the topical allopurinol against inflammation like skin dermatitis induced by1-isobutyl-1H-imidazo [4,5-c]quinolin-4-amine (IQA) in mice model. The current study allocated the thirty-two mice into four groups (n=8) as follows: i) control group, mice where a white petroleum jelly base applied topically on the dorsal of mice once daily; ii) induction group, mice were received IQA cream (62.5 mg) of (5%) on their back once daily; and iii) the treatment group, mice were treated with both (62.5 mg) of (5%) IQA and (5%) allopurinol gel topically; the betamethasone group, mice were treated with both (62.5 mg) of (5%) IQA and betamethasone ointment topically. All groups were treated daily for seven days period. The allopurinol-treated group exerted non-significant differences compared with the induction group in both visional and histopathological changes. The present study revealed that the allopurinolgel (5%) did not affect skin inflammation- induced by IQA in the laboratory mice.
- 31 October 2022
- Vol. 77 (5) , 1945-1952
Pharmaceutical Characterization and in vivo Evaluation of the Possible Anti-Inflammatory Effect of Topical Allopurinol Gel in an Animal Model
Dermatitis, like inflammation, is a group of common dermatological symptoms and may be associated with systemic and skin diseases. The objective of the current study is to evaluate the potential anti-inflammatory effect of the topical allopurinol against inflammation like skin dermatitis induced by1-isobutyl-1H-imidazo [4,5-c]quinolin-4-amine (IQA) in mice model. The current study allocated the thirty-two mice into four groups (n=8) as follows: i) control group, mice where a white petroleum jelly base applied topically on the dorsal of mice once daily; ii) induction group, mice were received IQA cream (62.5 mg) of (5%) on their back once daily; and iii) the treatment group, mice were treated with both (62.5 mg) of (5%) IQA and (5%) allopurinol gel topically; the betamethasone group, mice were treated with both (62.5 mg) of (5%) IQA and betamethasone ointment topically. All groups were treated daily for seven days period. The allopurinol-treated group exerted non-significant differences compared with the induction group in both visional and histopathological changes. The present study revealed that the allopurinolgel (5%) did not affect skin inflammation- induced by IQA in the laboratory mice.
- Open Access
- 21 March 2021
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (1) , 467-477
Effects of Vitamin D Supplementation on Healthy, Overweight, and Obese Adults: A Non-Blinded, Randomized Trial
A growing body of literature recognizes the role of vitamin D deficiency in various health-related problems such as obesity, cardiovascular diseases, and dyslipidemia. Hence, we design a small non-blinded randomized clinical study to explore some of these effects. The primary outcome was to investigate whether supplementation with vitamin D could reduce body mass index (BMI), while the secondary outcome was to see its effects on blood pressure (BP), serum total cholesterol (TC), and HDL-cholesterol over 12 weeks period in overweight otherwise healthy individuals. Twenty-two subjects were randomized into two groups, group A was given vitamin D supplementation of 200 IU/day and group B was assigned to 2000 IU/day. A baseline assessment of body mass index (BMI), blood pressure (BP), serum total cholesterol (TC), and serum HDL-cholesterol was performed at baseline, 4, 8, and 12 weeks. Repeated measure ANOVA was used to determine the effect of supplements within subjects and between the groups of our study. The study was unable to demonstrate any statistically significant effects of these supplemental doses of vitamin D on both primary and secondary outcomes over the study period. The scope of this study was limited by a small sample size and a large randomized double-blinded clinical study could provide more definitive evidence.
- 21 March 2021
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (1) , 467-477
Open AccessEffects of Vitamin D Supplementation on Healthy, Overweight, and Obese Adults: A Non-Blinded, Randomized Trial
A growing body of literature recognizes the role of vitamin D deficiency in various health-related problems such as obesity, cardiovascular diseases, and dyslipidemia. Hence, we design a small non-blinded randomized clinical study to explore some of these effects. The primary outcome was to investigate whether supplementation with vitamin D could reduce body mass index (BMI), while the secondary outcome was to see its effects on blood pressure (BP), serum total cholesterol (TC), and HDL-cholesterol over 12 weeks period in overweight otherwise healthy individuals. Twenty-two subjects were randomized into two groups, group A was given vitamin D supplementation of 200 IU/day and group B was assigned to 2000 IU/day. A baseline assessment of body mass index (BMI), blood pressure (BP), serum total cholesterol (TC), and serum HDL-cholesterol was performed at baseline, 4, 8, and 12 weeks. Repeated measure ANOVA was used to determine the effect of supplements within subjects and between the groups of our study. The study was unable to demonstrate any statistically significant effects of these supplemental doses of vitamin D on both primary and secondary outcomes over the study period. The scope of this study was limited by a small sample size and a large randomized double-blinded clinical study could provide more definitive evidence.
- Open Access
- 15 April 2019
- Published by GP Innovations Pvt. Ltd. in International Journal of Research in Pharmaceutical Sciences
- Vol. 10 (2) , 795-802
Effect of metformin gel against imiquimod–induced psoriasis in mice
Imiquimod-induced psoriasis is an animal model of psoriasis. The antidiabetic metformin had anti-inflammatory, immunomodulation, antiangiogenesis and antiproliferative effect. The objective of this study was to evaluate the possible beneficial effect of metformin gel against imiquimod-induced psoriasis-like form by scoring the erythema and scaling besides measuring of tissue homogenate levels of IL17/IL23. Swiss albino mice were used in this experiment imiquimod 5% cream applied on shaved back of mice for six days, and this is an induction group and compared with a negative control group that involved mice treated with ointment base only for six days. Third group; metformin 10% gel applied on the back of mice with imiquimod for six days. The fourth group included used of metformin 15% gel with imiquimod for six days. This data was analysed for significant level when p ≥ 0.05 by using either ANOVA test for biochemical parameters levels evaluation. Furthermore, imiquimod 5% cream of induction group caused an elevation of inflammatory parameters; IL17 and IL23 in skin tissue homogenate when being compared to IL17 and IL23 level of the control group. Whereas, metformin 10% gels showed levels of IL17 and IL23 with significant different from induction group. In addition, metformin 15% gels exerted a significantly low level of IL17 and IL23. The possible considerable antipsoriatic activity of topical metformin gel through reducing scaling and erythema and mediated through modest anti-inflammatory effects by suppressing levels of IL17/23.
- 15 April 2019
- Published by GP Innovations Pvt. Ltd. in International Journal of Research in Pharmaceutical Sciences
- Vol. 10 (2) , 795-802
Open AccessEffect of metformin gel against imiquimod–induced psoriasis in mice
Imiquimod-induced psoriasis is an animal model of psoriasis. The antidiabetic metformin had anti-inflammatory, immunomodulation, antiangiogenesis and antiproliferative effect. The objective of this study was to evaluate the possible beneficial effect of metformin gel against imiquimod-induced psoriasis-like form by scoring the erythema and scaling besides measuring of tissue homogenate levels of IL17/IL23. Swiss albino mice were used in this experiment imiquimod 5% cream applied on shaved back of mice for six days, and this is an induction group and compared with a negative control group that involved mice treated with ointment base only for six days. Third group; metformin 10% gel applied on the back of mice with imiquimod for six days. The fourth group included used of metformin 15% gel with imiquimod for six days. This data was analysed for significant level when p ≥ 0.05 by using either ANOVA test for biochemical parameters levels evaluation. Furthermore, imiquimod 5% cream of induction group caused an elevation of inflammatory parameters; IL17 and IL23 in skin tissue homogenate when being compared to IL17 and IL23 level of the control group. Whereas, metformin 10% gels showed levels of IL17 and IL23 with significant different from induction group. In addition, metformin 15% gels exerted a significantly low level of IL17 and IL23. The possible considerable antipsoriatic activity of topical metformin gel through reducing scaling and erythema and mediated through modest anti-inflammatory effects by suppressing levels of IL17/23.